17.13 USD
↗ 1.10 (6.83%)AT CLOSE (03:59 PM EDT)
Greenwich LifeSciences, Inc.
GLSINASDAQ • USD
17.04
↘ 0.09 (0.51%)
POST MARKET (AS OF 04:34 PM EDT)
Post Market
AS OF 04:34 PM EDT
17.04
↘ 0.09 (0.51%)
Market: OPEN
GLSI is currently priced at $17.04. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Oct 23, 2026.
Open?$16.01
High?$17.44
Low?$15.86
Prev. Close?$16.03
Volume?118.0K
Avg. Volume?132.3K
VWAP?$16.70
Rel. Volume?0.89x
Bid / Ask
Bid?$13.98 × 100
Ask?$19.80 × 100
Spread?$5.82
Midpoint?$16.89
Valuation & Ratios
Market Cap?235.3M
Shares Out?14.7M
Float?6.3M
Float %?43.2%
P/E Ratio?N/A
P/B Ratio?75.49
EPS?-$1.48
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9-amino-acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including breast cancers at low (1+), intermediate (2+), and high (3+ or overexpressing) levels.
Employees
13
Market Cap
235.3M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2020-09-25
Address
3992 BLUEBONNET DR, BUILDING 14
STAFFORD, TX 77477
Phone: 203-434-3290
STAFFORD, TX 77477
Phone: 203-434-3290
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?22
Momentum?50
Short Sent.?19
Piotroski F-Score?0/9Weak
Altman Z-Score?1.55Distress
Confidence?55%Low
Short InterestSqueeze Risk
Short % of Float?24.93%Squeeze Risk
Short Interest?1.6M
Days to Cover?11.4
Free Float6.3M
Avg Daily Volume139.0K
Settlement Date2026-09-30
Financial Health
Current Ratio?1.54Adequate
Quick Ratio?1.54Adequate
Cash Ratio?1.54Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?75.49HIGH▾
Peers100
S&P3
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-10.4CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-695.6%WEAK▾
S&P3
ROA?-244.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-12488140
Enterprise Value?$226.4M
Fundamentals ratios updated end of day